BNTC — Benitec Biopharma Cashflow Statement
0.000.00%
Last trade - 00:00- $405.67m
- $311.19m
- 43
- 20
- 90
- 50
Annual cashflow statement for Benitec Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.9 | -18.2 | -19.6 | -21.8 | -37.9 |
| Depreciation | |||||
| Non-Cash Items | 0.811 | 1.1 | 0.7 | 1.09 | 17 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.008 | 1.04 | 0.714 | 1.17 | -2.73 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -12.8 | -15.9 | -18 | -19.4 | -23.6 |
| Capital Expenditures | -0.221 | -0.013 | -0.001 | -0.179 | -0.018 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.221 | -0.013 | -0.001 | -0.179 | -0.018 |
| Financing Cash Flow Items | -3.23 | 0 | -1.87 | -5.89 | -2.32 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 22.5 | 0 | 16 | 68 | 70.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.97 | -15.7 | -1.59 | 48.4 | 46.9 |